No Data
Third Quarter Report 2024
The amount of money raised for the investment project has been significantly reduced, indicating that YINUOSI is testing the 'temperature' of the CRO industry.
①Yinuo Si originally planned to raise 1.602 billion yuan, but only raised 0.672 billion yuan in reality, had to significantly reduce the investment amount of some raised projects, and also cancelled the supplementary flow project. ②Due to the impact of the slowdown in investment and financing, china meheco group's R&D expenditure growth rate has also begun to slow down, including Yinuo Si, many upstream CRO companies' performance has been affected.
Yinuo (688710.SH): The company and its wholly-owned subsidiaries have obtained OECD GLP certification.
Geelong October 8th | Yinosi (688710.SH) announced that the company and its wholly-owned subsidiary Yinosi Biotechnology Nantong Co., Ltd. (referred to as Yinosi Nantong) GLP laboratories have recently received GLP certificates issued by the National Public Health and Pharmaceutical Center of Hungary (NNGYK). This OECDGLP certification inspection is the fifth OECDGLP certification inspection conducted by Yinosi Shanghai, and the first OECDGLP certification inspection conducted by Yinosi Nantong. Both the company and its wholly-owned subsidiary Yinosi Nantong have successfully obtained the GLP certificates issued by the National Public Health and Pharmaceutical Center of Hungary.
Shanghai InnoStar Bio-tech Opens 60% Above IPO Price
Express News | Shanghai Innostar Bio-Tech Says Trading in Shares to Debut on Sept 3 in Shanghai
Yinuo Si (688710.SH): will be listed on the STAR Market on September 3rd.
Yinuosi (688710.SH) announced that the company's stocks will be traded on the Shanghai Stock Exchange on September 3, 2024...